Sequent Scientific Ltd


BSE: 512529 | NSE: NA | ISIN: INE807F01019 
Market Cap: [Rs.Cr.] 332 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Profit & Loss

(Rs. in Crores)
ParticularsMar-12Mar-11Mar-10Mar-09Mar-08Mar-07
INCOME :      
Sales Turnover 345.08286.73253.14111.2973.8740.12
Excise Duty12.658.756.805.236.473.15
Net Sales332.43277.98246.34106.0667.4036.97
Other Income 11.3312.467.291.790.393.13
Stock Adjustments -0.6112.917.725.51-1.860.37
Total Income343.15303.35261.35113.3665.9340.47
EXPENDITURE :      
Raw Materials 189.26153.17111.4656.2637.1518.72
Power & Fuel Cost20.2115.6813.686.633.612.76
Employee Cost 25.4422.7117.927.463.611.72
Other Manufacturing Expenses 22.1828.2225.7414.547.864.53
Selling and Administration Expenses 19.8217.8820.008.265.851.79
Miscellaneous Expenses 19.436.2610.936.350.830.51
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure296.34243.92199.7399.5058.9130.03
Operating Profit46.8159.4361.6213.867.0210.44
Interest 28.2720.0418.734.191.850.28
Gross Profit18.5439.3942.899.675.1710.16
Depreciation21.0317.1812.524.142.431.09
Profit Before Tax-2.4922.2130.375.532.749.07
Tax0.092.020.831.830.171.21
Fringe Benefit tax0.000.000.000.110.050.02
Deferred Tax-4.054.268.750.070.490.17
Reported Net Profit1.4715.9320.793.522.037.67
Extraordinary Items 6.443.05-2.270.010.002.41
Adjusted Net Profit-4.9712.8823.063.512.035.26
Adjst. below Net Profit 0.00-3.882.450.000.000.00
P & L Balance brought forward37.0529.6412.9210.8010.494.50
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.004.646.521.401.721.68
P & L Balance carried down38.5237.0529.6412.9210.8010.49
Dividend0.003.294.241.111.390.75
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.0015.0020.0010.0010.0010.00
Earnings Per Share-Unit Curr0.697.249.453.001.6210.05
Earnings Per Share(Adj)-Unit Curr0.697.249.453.001.6210.05
Book Value-Unit Curr59.3859.1154.5553.7348.3741.73

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 33,524.51 26.59 6.92 21.23 23.4 22.7 0.30
Divi's Lab. 13,013.48 21.28 5.10 13.41 27.3 34.1 0.02
Jubilant Life 2,279.58 28.97 1.22 21.18 3.1 6.4 1.43
Shilpa Medicare 706.21 14.10 2.42 9.34 16.3 18.0 0.19
Hikal 673.96 26.41 1.96 5.65 22.4 18.2 1.53
Elder Pharma 557.56 6.06 0.72 6.59 12.9 13.0 1.25
Dishman Pharma. 551.18 11.38 0.82 5.44 6.8 10.2 0.80
Vinati Organics 536.93 7.82 2.23 5.63 33.2 31.3 0.75
Shasun Pharma. 424.78 15.41 1.57 7.48 14.0 8.9 1.05
Orchid Chemicals 413.54 0.00 0.45 7.67 9.7 8.3 1.75
Nectar Lifesci. 357.09 4.17 0.41 6.25 9.7 11.2 1.22
Sequent Scien. 331.75 0.00 2.17 7.62 -3.9 5.9 1.58
Suven Life Scie. 283.82 9.20 1.84 10.21 11.3 9.1 0.64
Aarti Drugs 257.03 5.64 1.24 4.78 13.5 13.7 1.48
Granules India 254.95 8.45 0.94 4.12 11.7 15.2 0.57

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

K R Ravishankar , Chairman & Managing Director  

Gopakumar G Nair , Director  

Kannan Ramanujam , Director  

Gautam Kumar Das , Executive Director  


Company Head Office / Quarters:
301 Dosti Pinnacle 3rd Floor,
Plot E7 Road No 22 Wagle Indl,
Thane,
Maharashtra-400604
Phone :
Fax :
E-mail : pidsecretarial@yahoo.co.in
Web : http://www.pidrugs.com
Registrars:
Adroit Corp. Services Pvt Ltd
19/20 Jaferbhoy Ind
1st Floor Makwana Rd
Marol Naka
Mumbai - 400 059

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Opening : India Finsec
Economic Events
list Balance (YTD) (New Zealand dollars)
list Cap Goods Orders Nondef Ex Air
Results
list Britannia Inds. | Crompton Greaves | M R P L | Jet Airways